Sewing KF |
Pharmacokinetics, dosing principles, and blood level monitoring of FK506. |
1994 |
Transplant. Proc. |
pmid:7527962
|
Klintmalm GB et al. |
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679828
|
Wachtman GS et al. |
Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. |
2011 |
Transplant. Proc. |
pmid:22099837
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506 in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721261
|
Washburn WK et al. |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8623214
|
Fitzsimmons WE et al. |
Demographic considerations in tacrolimus pharmacokinetics. |
1998 |
Transplant. Proc. |
pmid:9636552
|
Jang HJ et al. |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis. |
2000 |
Transplant. Proc. |
pmid:11119904
|
Chakkera HA et al. |
Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375287
|
Burke GW et al. |
Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement. |
1998 |
Transplant. Proc. |
pmid:9532223
|
Tian Ch et al. |
B- and T-lymphocyte attenuator/herpes virus entry mediator as early indicators for acute rejection following kidney transplantation. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375291
|
Sahar G et al. |
Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine. |
2003 |
Transplant. Proc. |
pmid:12644092
|
Vilalta R et al. |
Delayed graft function is reduced with antithymocyte globulin induction in pediatric kidney transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715923
|
Imventarza O et al. |
Renal transplantation in baboons under FK 506. |
1990 |
Transplant. Proc. |
pmid:1689903
|
Sgrosso JL et al. |
Tacrolimus pharmacokinetics in heart transplant. |
2002 |
Transplant. Proc. |
pmid:11959225
|
Žilinská Z et al. |
Impact of Trough Levels of Tacrolimus on Kidney Function and Graft Survival in Short and Longer Periods After Renal Transplantation. |
2016 |
Transplant. Proc. |
pmid:27788794
|
Akselband Y et al. |
Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. |
1991 |
Transplant. Proc. |
pmid:1721292
|
Schreiber SL et al. |
Immunophilin-ligand complexes as probes of intracellular signaling pathways. |
1991 |
Transplant. Proc. |
pmid:1721293
|
Maggard M et al. |
Incidence of acute rejection in African-American liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636607
|
Yamaguchi M et al. |
FK 506 significantly improves transferred insulin gene expression in total pancreatectomized dogs. |
2000 |
Transplant. Proc. |
pmid:11120255
|
Butt TR et al. |
Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506. |
1996 |
Transplant. Proc. |
pmid:8623486
|
Mueller AR et al. |
Influence of immunosuppression on patient outcome after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636608
|
Yoshida S et al. |
Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats. |
2000 |
Transplant. Proc. |
pmid:11120262
|
Morales JM et al. |
Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid. |
1999 |
Transplant. Proc. |
pmid:10576051
|
Jordan ML et al. |
Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. |
1999 |
Transplant. Proc. |
pmid:10576052
|
Nishikawa S et al. |
Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. |
2009 |
Transplant. Proc. |
pmid:19917404
|
Pérez-Flores I et al. |
Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus. |
2010 |
Transplant. Proc. |
pmid:20970565
|
Marzorati S et al. |
Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249555
|
Spada M et al. |
Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518142
|
Kai N et al. |
A study on the timing of immunologic priming in autoimmune insulitis in NOD mice. |
1992 |
Transplant. Proc. |
pmid:1376511
|
Langrehr JM et al. |
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. |
1995 |
Transplant. Proc. |
pmid:7533373
|
Nakata S et al. |
Immunosuppressive effect of FK 506 on cytotoxic T lymphocytes and delayed-type hypersensitivity in rats. |
1991 |
Transplant. Proc. |
pmid:1721325
|
Liu B et al. |
Single-center experience: tacrolimus and mycophenolate mofetil in early stage of kidney transplantation with liver dysfunction. |
2003 |
Transplant. Proc. |
pmid:12591396
|
Nakamura K et al. |
Renal transplant recipient experiencing pneumatosis cystoides intestinalis: a case report. |
2003 |
Transplant. Proc. |
pmid:12591410
|
Iwahori T et al. |
Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy. |
2005 |
Transplant. Proc. |
pmid:15919450
|
Takeuchi H et al. |
Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters. |
2005 |
Transplant. Proc. |
pmid:15919452
|
Sarvary E et al. |
De novo Prograf versus de novo Advagraf: are trough level profile curves similar? |
|
Transplant. Proc. |
pmid:25131131
|
Varo E et al. |
Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. |
2002 |
Transplant. Proc. |
pmid:12176481
|
Winkler M et al. |
Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring. |
1995 |
Transplant. Proc. |
pmid:7533433
|
Odoul F et al. |
Massive ingestion of tacrolimus in a young liver transplant patient. |
1998 |
Transplant. Proc. |
pmid:9865375
|
Van Thiel DH et al. |
Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721357
|
Weber M et al. |
Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy. |
1997 |
Transplant. Proc. |
pmid:9414883
|
Deniz H et al. |
Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats. |
2006 |
Transplant. Proc. |
pmid:16549154
|
Fisniku O et al. |
Protective effects of PG490-88 on chronic allograft rejection by changing intragraft gene expression profiles. |
2005 |
Transplant. Proc. |
pmid:15919518
|
Jiménez O et al. |
Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12962758
|
Cotovio P et al. |
New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes. |
2013 |
Transplant. Proc. |
pmid:23622631
|
Cronin DC et al. |
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123010
|
Teebken OE et al. |
Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12072335
|
Rossi G et al. |
Results of orthotopic liver-small bowel transplantation in the pig using different immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907932
|
Burke GW et al. |
Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection. |
2002 |
Transplant. Proc. |
pmid:12176505
|
Meçule A et al. |
Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen. |
2011 |
Transplant. Proc. |
pmid:21620042
|
Kaufman DB et al. |
Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083261
|
Stratta RJ |
Optimal immunosuppression in pancreas transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083263
|
Takagishi K et al. |
Effects of FK-506 on collagen arthritis in mice. |
1989 |
Transplant. Proc. |
pmid:2468205
|
Schmidt RJ et al. |
Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721390
|
Arita C et al. |
Effect of FK 506 (FR 900506) on collagen arthritis in rats: a preliminary report. |
1989 |
Transplant. Proc. |
pmid:2468206
|
Tze WJ et al. |
Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. |
1991 |
Transplant. Proc. |
pmid:1721391
|
Personett HA et al. |
Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case report. |
2014 |
Transplant. Proc. |
pmid:25017243
|
Guo Z et al. |
Leflunomide, a potential immunosuppressant for pancreatic islet transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123314
|
Gerbase MW et al. |
Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation. |
2001 |
Transplant. Proc. |
pmid:11377481
|
Yussim A et al. |
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. |
1996 |
Transplant. Proc. |
pmid:8962233
|
Walgenbach KJ et al. |
Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123418
|
Sifontis NM et al. |
Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176554
|
Gerhardt U et al. |
High QT dispersion in tacrolimus-treated kidney transplant recipients. |
2001 |
Transplant. Proc. |
pmid:11377482
|
Golling M et al. |
Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962234
|
Toda F et al. |
Tacrolimus trough level adjustment after administration of fluconazole to kidney recipients. |
2002 |
Transplant. Proc. |
pmid:12176555
|
Platz KP et al. |
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. |
1996 |
Transplant. Proc. |
pmid:8962235
|
Ju MK et al. |
A 6-month, open-label, multicenter clinical study in Korean de novo renal transplant patients evaluating the efficacy, safety, and tolerance of myfortic concomitantly used with tacrolimus. |
2012 |
Transplant. Proc. |
pmid:22310600
|
Ciancio G et al. |
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267169
|
Boggs S et al. |
FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice. |
1991 |
Transplant. Proc. |
pmid:1721420
|
Ogawa N et al. |
Suppressive effects of combination therapy with mizoribine and FK 506 on the development of accelerated coronary artery disease and myocardial rejection after heart transplantation. |
1996 |
Transplant. Proc. |
pmid:8658710
|
Pan D et al. |
Tacrolimus-associated Diffuse Gastrointestinal Ulcerations and Pathergy: A Case Report. |
|
Transplant. Proc. |
pmid:28104141
|
Dick TB et al. |
Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients. |
2011 |
Transplant. Proc. |
pmid:21911143
|
Zucker MJ et al. |
De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis. |
2005 |
Transplant. Proc. |
pmid:15964386
|
Gridelli B et al. |
Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723311
|
Kiberd BA et al. |
Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period. |
2005 |
Transplant. Proc. |
pmid:15964408
|
Hummel AD et al. |
Application of artificial neural networks in renal transplantation: classification of nephrotoxicity and acute cellular rejection episodes. |
2010 |
Transplant. Proc. |
pmid:20304167
|
Wiseman AC et al. |
Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience. |
2003 |
Transplant. Proc. |
pmid:12742482
|
Holt DW et al. |
Therapeutic monitoring of sirolimus: its contribution to optimal prescription. |
2003 |
Transplant. Proc. |
pmid:12742490
|
Webb NJ et al. |
Pharmacokinetics of tacrolimus in paediatric renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176639
|
Collin C et al. |
Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study. |
2010 |
Transplant. Proc. |
pmid:21168693
|
Sundberg AK et al. |
Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes. |
2002 |
Transplant. Proc. |
pmid:12176640
|
Li ZY et al. |
Analytical performance of the Abbott Architect i2000 tacrolimus assay in Chinese patients after renal transplantation. |
2010 |
Transplant. Proc. |
pmid:21168731
|
Veroux M et al. |
Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. |
2006 |
Transplant. Proc. |
pmid:16757256
|
Mohamed MA et al. |
TGF-beta expression in protocol transplant liver biopsies: a comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267336
|
Shokouh-Amiri MH et al. |
The importance of early prevention of renal dysfunction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267345
|
Murio JE et al. |
Compassionate use of FK 506 in liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7544501
|
Abu-Elmagd K et al. |
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. |
1991 |
Transplant. Proc. |
pmid:1721451
|
Cofan F et al. |
Oxidation of low-density lipoproteins in renal transplant recipients. |
1999 |
Transplant. Proc. |
pmid:10500604
|
Reiner J et al. |
After Intestinal Transplantation Kidney Function Is Impaired by Downregulation of Epithelial Ion Transporters in the Ileum. |
2016 |
Transplant. Proc. |
pmid:27109987
|
Thomson AW et al. |
Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study. |
1991 |
Transplant. Proc. |
pmid:1721452
|
GarcÃa González M et al. |
Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation. |
1999 |
Transplant. Proc. |
pmid:10500620
|
Rao B et al. |
Use of Everolimus After Multivisceral Transplantation: A Report of Two Cases. |
2016 |
Transplant. Proc. |
pmid:27109983
|
|
Immunosuppression: FK506. |
1988 |
Transplant. Proc. |
pmid:2450415
|
Todo S et al. |
Effect of FK506 in experimental organ transplantation. |
1988 |
Transplant. Proc. |
pmid:2450416
|
Yoshimura R et al. |
A comparative study between cyclosporine and FK 506 effects on renal microsomal P-450. |
1991 |
Transplant. Proc. |
pmid:1703686
|
Miyagawa S et al. |
Mechanism of unresponsiveness in rats induced by a short course of FK 506 or CyA. |
1991 |
Transplant. Proc. |
pmid:1703687
|
Kinukawa T et al. |
Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor. |
1998 |
Transplant. Proc. |
pmid:9636498
|
Morris-Stiff G et al. |
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636499
|
Alak AM and Moy S |
Biological activity of tacrolimus (FK506) and its metabolites from whole blood of kidney transplant patients. |
1997 |
Transplant. Proc. |
pmid:9270821
|
Scholler G et al. |
Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation. |
1997 |
Transplant. Proc. |
pmid:9270822
|